We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
Cap. Flow
+$410M
Cap. Flow %
8.05%
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$965M
2
DLR icon
Digital Realty Trust
DLR
+$229M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$144M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$143M
5
SMCI icon
Super Micro Computer
SMCI
+$139M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$102M
2
NVDA icon
NVIDIA
NVDA
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
GFS icon
GlobalFoundries
GFS
+$80.1M
5
MDLN
Medline Inc
MDLN
+$62.3M

Sector Composition

Rank Sector Weight
1 Industrials 29.61%
2 Miscellaneous 19.42%
3 Communication Services 10.49%
4 Technology 8.3%
5 Healthcare 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBMT
276
Silver Bow Mining Corp
SBMT
$257M
$676K 0.01%
+100,000
New +$884K
PBLS
277
Parabilis Medicines Inc
PBLS
$4.83B
$547K 0.01%
+20,000
New +$552K
SPTX
278
Seaport Therapeutics
SPTX
$1.29B
$543K 0.01%
+25,000
New +$440K
BTU icon
279
Peabody Energy
BTU
$3.53B
$532K 0.01%
+23,000
New +$611K
ITG
280
ITG Inc
ITG
$596M
$528K 0.01%
+33,000
New +$528K
SVIV
281
Spring Valley Acquisition Corp IV
SVIV
$313M
$510K 0.01%
+50,000
New +$503K
CMII
282
Columbus Circle Capital Corp II
CMII
$507K 0.01%
+50,000
New +$497K
MESH
283
Meshflow Acquisition Corp
MESH
$435M
$501K 0.01%
50,000
– –
ODTX
284
Odyssey Therapeutics
ODTX
$1.17B
$468K 0.01%
+25,000
New +$438K
JBIO
285
Jade Biosciences
JBIO
$1.33B
$444K 0.01%
+20,000
New +$417K
KEEL
286
Keel Infrastructure Corp
KEEL
$1.99B
$435K 0.01%
+75,700
New +$325K
HUMA icon
287
Humacyte
HUMA
$181M
$390K 0.01%
+500,000
New +$463K
NWAX
288
New America Acquisition I Corp
NWAX
$507M
$305K 0.01%
30,000
– –
BTGO
289
BitGo Holdings
BTGO
$806M
$259K 0.01%
50,000
-30,000
-38% -$246K
HCMA
290
HCM III Acquisition Corp
HCMA
$347M
$257K 0.01%
25,000
– –
OCAC.U
291
Ocean Capital Acquisition Corp Units
OCAC.U
$256K 0.01%
+25,000
New +$255K
CRVS icon
292
Corvus Pharmaceuticals
CRVS
$1.19B
$149K ﹤0.01%
10,000
– –
VRDN icon
293
Viridian Therapeutics
VRDN
$2.61B
$129K ﹤0.01%
+7,000
New +$113K
AVAT
294
Avalanche Treasury Corp
AVAT
$24.7M
$101K ﹤0.01%
+201,924
New +$193K
IEAGR
295
Infinite Eagle Acquisition Corp Rights
IEAGR
$87.8K ﹤0.01%
450,000
– –
HCICR
296
Hennessy Capital Investment Corp VIII Share Rights
HCICR
$80.5K ﹤0.01%
+500,000
New +$82.2K
DMIIR
297
Drugs Made In America Acquisition II Corp Right
DMIIR
$54.5K ﹤0.01%
750,000
– –
SSACR
298
SPACSphere Acquisition Corp Rights
SSACR
$33.8K ﹤0.01%
+200,000
New +$33.9K
AACPR
299
Apogee Acquisition Corp Rights
AACPR
$22.5K ﹤0.01%
+125,000
New +$24K
XFLH.RT
300
XFLH Capital Corp Rights
XFLH.RT
$10.3K ﹤0.01%
+100,000
New +$11K
10 11
12
13 14

Similar funds

KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
YCM
Yaupon Capital Management New York $5.08B AUM 53.49% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
GIBU
Gulf International Bank (UK) London, United Kingdom $5.07B AUM 41.86% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $5.13B AUM 11.51% 1-Year Est. Return

Ghisallo Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.

  • Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
  • Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
  • Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
  • Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
  • Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
  • Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
  • Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.